MedPath

Efficacy of regimen of latakarnj beej churna and tamra bhasma as tab lamra and latakaranj beej churna as tab lata in aartavkshay in polycystic ovarian syndrome

Phase 2/3
Not yet recruiting
Conditions
Polycystic ovarian syndrome. Ayurveda Condition: ARTAVAKSHAYAH,
Registration Number
CTRI/2023/08/056670
Lead Sponsor
Dr Simran Abdulraheman Shaikh
Brief Summary

As PCOS Has 36% Prevalence It’s Becoming Burning Issue Regarding Women Reproductive Health

Current Study Is Randomized Controlled Clinical Trial To Check Effectiveness Of Regimen Of Latakaranj Beej Churna Plus Tamra Bhasma As Tab Lamra And Latakarnj Beej Churna As Tab Lata In Aartavkshay In PCOS Study Consists Of Two Trial Groups A B And One Control Group C

Drugs

A Group Tab Lamra 650 Mg First 45 Days From 5 th Day Of Menstrual Cycle Of Treatment Followed By Tab Lata 500 Mg For Next 135 Days Orally with water Before Meal

Group B Tab Lata From 5 th Day Of Menstrual Cycle To Next 180 Days Orally With Water Before Meal

Group C Tab Ovral L 5 th Day To 25 th Day Of Each Menstrual Cycle Of Treatment For Next 180 Days Orally With Water HS

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
66
Inclusion Criteria

Women Of Age Group 18-40 yrs Irrespective Of Marital Status Known Cases Of PCOS USG Showing Polycystic Appearance Patient Fulfilling Rotterdam Criteria Require Any Two Of Following Three Criteria For Diagnosis Of PCOS Oligomenorrhea And Amenorrhea Hyperandrogenism Clinical And Biochemical USG Suggestive Of Ovarian Volume Greater Than Or Equal To 10 Cm Cube Polycystic Ovaries Ovarian Diameter 2-9 mm.

Exclusion Criteria

Known Cases Of Fibroid Adenomyosis Endometriosis Anaemia Hb less than 7 Diabetes Mellitus Pregnant And Lactating Women Pittapradhan Prakruti.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Evaluate The Efficacy Of Regimen Of Tab Lamra Plus Tab Lata In Aartavkshay With Special Reference To Pcos4 weeks
Secondary Outcome Measures
NameTimeMethod
To Assess Properties Positive Effects And Untoward Effect Of Latakarnj Beej Churna And Tamra Bhasma Regarding Aartavkshay In PCOS

Trial Locations

Locations (1)

Hon Shri Annasaheb Dange Ayurved Medical College And Dhanvantari Ayurved Hospital Ashta

🇮🇳

Sangli, MAHARASHTRA, India

Hon Shri Annasaheb Dange Ayurved Medical College And Dhanvantari Ayurved Hospital Ashta
🇮🇳Sangli, MAHARASHTRA, India
Dr Simran Abdulraheman Shaikh
Principal investigator
7038911586
simranbams041@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.